重度主动脉瓣疾病患者心脏磁共振晚期钆增强的预后价值:系统评价与荟萃分析
该系统评价与荟萃分析纳入6项研究共626例重度主动脉瓣疾病患者,评估心脏磁共振晚期钆增强(LGE)对预后的预测价值。LGE阳性预测全因死亡的合并OR为3.28(95%CI 2.02-5.32,p<0.001),与心血管死亡相关(合并OR 3.10,95%CI 1.73-5.56,p<0.001),在主动脉瓣置换术后重度主动脉瓣狭窄患者中预测全因死亡的合并OR为2.30(95%CI 1.06-4.99,p=0.036)。
要点
- LGE阳性与重度主动脉瓣疾病患者全因死亡风险升高相关(合并OR 3.28,95%CI 2.02-5.32,p<0.001)。
- LGE阳性与心血管死亡风险升高相关(合并OR 3.10,95%CI 1.73-5.56,p<0.001)。
- 主动脉瓣置换术后重度主动脉瓣狭窄患者中,LGE阳性仍与全因死亡相关(合并OR 2.30,95%CI 1.06-4.99,p=0.036)。
核心结论
- CMR上的LGE是一种有前景的风险分层方法,可预测主动脉瓣疾病患者的全因死亡和心血管死亡,尤其是主动脉瓣狭窄;LGE-CMR在主动脉瓣置换术后患者中也有显著预后价值。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、EMBASE和Web of Science,纳入6项应用LGE-CMR评估重度主动脉瓣疾病预后意义并测量心肌纤维化的研究,共626例患者,随访时间0.5至5.7年。
关键影像表现/征象
- 原文未报告具体影像征象描述,仅以LGE阳性/阴性作为暴露因素。
诊断标准与关键数值
- LGE阳性 versus LGE阴性预测全因死亡的合并OR为3.28(95%CI 2.02-5.32;p<0.001)。
- LGE阳性与心血管死亡相关,合并OR为3.10(95%CI 1.73-5.56;p<0.001)。
- 主动脉瓣置换术后重度主动脉瓣狭窄患者中,LGE阳性预测全因死亡的合并OR为2.30(95%CI 1.06-4.99;p=0.036)。
临床应用与阅片要点
- 原文结论认为LGE-CMR是有前景的风险分层方法,可预测主动脉瓣疾病患者的全因死亡和心血管死亡。
- 原文结论认为LGE-CMR在主动脉瓣置换术后患者中也有显著预后价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the predictive value of late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) in patients with severe aortic valve disease.
MATERIALS AND METHODS: PubMed, EMBASE, and Web of Science were searched for studies applying LGE-CMR to assess prognostic significance in patients with severe aortic valve disease and to measure myocardial fibrosis (MF). The association of LGE with outcomes was estimated for each study by an odds ratio (OR) along with its 95% confidence interval (CI). Pooled estimates of ORs were calculated using a Mantel-Haenszel fixed-effects model.
RESULTS: Six studies including 626 patients were included in the meta-analysis. The follow-up period was from 0.5 to 5.7 years. The pooled OR was 3.28 (95% CI: 2.02-5.32; p<0.001) for LGE (+) versus LGE (-) in predicting patients with aortic valve disease in all-cause mortality. The presence of LGE was associated with cardiovascular mortality (pooled OR: 3.10, 95% CI: 1.73-5.56; p<0.001). The presence of LGE was associated with all-cause mortality in patients with severe aortic stenosis after aortic valve replacement (pooled OR: 2.30, 95% CI: 1.06-4.99; p=0.036).
CONCLUSION: LGE on CMR is a promising risk stratification method, as it could predict all-cause mortality and cardiovascular mortality in patients with aortic valve disease, especially for aortic stenosis. LGE-CMR also has significant prognostic value in patients after aortic valve replacement.
引用
- Chen H, Zeng J, Liu D, et al. Prognostic value of late gadolinium enhancement on CMR in patients with severe aortic valve disease: a systematic review and meta-analysis. Clin Radiol. 2018. PMID: 30086859. doi:10.1016/j.crad.2018.07.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。